Skip to content

LifeMD, Inc. LFMD Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

CVS Health logo
CVS HealthCVS
Spok Holdings logo
Spok HoldingsSPOK
Teladoc Health logo
Teladoc HealthTDOC
DocGo logo
DocGoDCGO
PTH
Pelthos Therapeutics Inc.PTHS
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM

Other financials

Income statement

See full
Revenue$50.2M-1.4%
Gross profit$44.2M+3.5%
Operating income-$8.9M-656%
Net income-$8.9M-4,728%
EPS (diluted)-$0.20-900%

Balance sheet

See full
Cash & equivalents$34.5M+7.9%
Total debt$6.2M-76.9%
Total equity$15.0M+746%
Total assets$70.1M-4.7%

Cash flow

See full
Operating cash flow$444.6K-85.5%
CapEx$105.2K-10.5%
Free cash flow$339.4K-88.5%

Valuation

See full
Market cap$235.53M-61.7%
Enterprise value$207.22M-66.2%
P/E41.6×
P/S1.3×-2.3×

Profitability

See full
Gross margin86.1%+0.9pp
Operating margin-9.8%-0.9pp
Net margin3.1%+1.8pp
FCF margin10.4%+1.7pp

Returns & leverage

See full
Return on equity-393.6%
Debt / equity0.4×
Current ratio+0.2×

Where this comes from

Reported directly by LifeMD, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: LifeMD, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LifeMD, Inc.'s common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LifeMD, Inc.'s common stock, shares authorized (in shares)?
LifeMD, Inc. (LFMD) reported common stock, shares authorized (in shares) of $100M in Q1 2026.
How has LifeMD, Inc.'s common stock, shares authorized (in shares) changed year-over-year?
LifeMD, Inc.'s common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $100M to $100M.
What is the long-term trend for LifeMD, Inc.'s common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), LifeMD, Inc.'s common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $100M to $100M.